JMP Securities Keeps Their Buy Rating on Sprinklr (CXM)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr (CXM – Research Report) today and set a price target of $17.00.
JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
Unity Software’s (U) Market Perform Rating Reiterated at JMP Securities
Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...